Legacy Capital Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.89M Buy
3,241
+137
+4% +$140K 1.79% 22
2026
Q1
$2.85M Buy
3,104
+160
+5% +$162K 1.64% 31
2025
Q4
$3.16M Buy
+2,944
New +$2.81M 1.92% 19
2024
Q4
$1.2M Buy
+1,557
New +$1.29M 1.19% 30

Other funds holding LLY

Legacy Capital Wealth Management's LLY Position: Q2 2026 in Review

Legacy Capital Wealth Management increased its Eli Lilly (LLY) stake by 4.4% in Q2 2026, buying an estimated $140K and bringing the position to 3,241 shares worth $3.89M. The position accounts for 1.79% of the portfolio, ranked #22.

Legacy Capital Wealth Management first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. 4,612 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Legacy Capital Wealth Management held 3,241 shares of Eli Lilly worth $3.89M as of Q2 2026.
  • Legacy Capital Wealth Management bought 137 Eli Lilly shares in Q2 2026, an estimated $140K.
  • Eli Lilly made up 1.79% of Legacy Capital Wealth Management's portfolio in Q2 2026, its #22 holding.
  • Legacy Capital Wealth Management first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
  • 4,612 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Legacy Capital Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.